ARRIVENT BIOPHARMA, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2023 | — | $-74.6M | $-69.3M |
| FY2024 | — | $-94.3M | $-80.5M |
| FY2025 | — | $-177.5M | $-166.3M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2023 | — | $-74.6M | $-69.3M |
| FY2024 | — | $-94.3M | $-80.5M |
| FY2025 | — | $-177.5M | $-166.3M |